BRK-B vs JOF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
JOF presents a compelling deep-value opportunity, characterized by a stable Piotroski F-Score of 4/9 and a current price ($10.99) trading at a significant discount to both its Graham Number ($22.65) and Intrinsic Value ($16.87). The fund exhibits an exceptionally low P/E ratio of 4.56 compared to the sector average of 35.45, paired with a highly sustainable 9.69% dividend yield. While technical trends are currently bearish (0/100), the strong long-term price performance and robust revenue growth of 42.3% suggest a strong fundamental floor.
Compare Another Pair
Related Comparisons
BRK-B vs JOF: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Japan Smaller Capitalization Fund, Inc. (JOF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.